Abstract P3-06-07: Phase Ib/II Study to Evaluate Safety and Tolerability of Cabiralizumab in Combination with Nivolumab and Neoadjuvant Chemotherapy in Patients with Localized Triple-Negative Breast Cancer
Cancer research(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要